Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Choosing sectors for retirement requires matching income needs with risk tolerance. This guide highlights practical picks to support steady retirement cash flow.
23,834 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A game-changing cloud contract could reshape SpaceX’s IPO narrative. This article breaks down what google's $920 mill...
A regulatory milestone sparked a notable move for Oklo shares, highlighting how news on licensing can lift niche ener...
Two heavyweight tech stocks have surged on AI bets, but investors face a stark choice: own NVIDIA stock or Micron sto...
Shares of SMCI jumped 11% and Dell rose 5% after NVIDIA unveiled Vera Rubin at ISC High Performance 2026, reigniting ...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Despite a modest headline fee, the SPDR S&P Semiconductor ETF trails cheaper rivals on longer horizons, signaling a h...
Tesla shares rise on stronger robotaxi momentum and robust delivery data, sparking a broader EV rally as Rivian, Luci...
Netflix beat revenue but faced a big one-time charge, boosting cash flow guidance. Spotify posted a strong EPS beat b...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...
A nuclear stock down 46% this year may look tempting, but ambition must be balanced with diligence. This guide breaks...
A practical guide to organizing your real estate investor document so you never miss a deductible expense. Learn a mo...